EU/1/18/1279/002 |
8320C |
AMGLIDIA 0,6 mg/ml perorálna suspenzia |
sus por 1x30 ml/18 mg (f?.skl.hnedá+5 ml per.striek.) |
AMK |
24.05.2023 |
EU/1/18/1279/001 |
8319C |
AMGLIDIA 0,6 mg/ml perorálna suspenzia |
sus por 1x30 ml/18 mg (f?.skl.hnedá+1 ml per.striek.) |
AMK |
24.05.2023 |
EU/1/07/391/009 |
6549B |
Revlimid 20 mg tvrdé kapsuly |
cps dur 21x20 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/011 |
5367C |
Revlimid 15 mg tvrdé kapsuly |
cps dur 7x15 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/010 |
5366C |
Revlimid 10 mg tvrdé kapsuly |
cps dur 7x10 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/008 |
6809A |
Revlimid 5 mg tvrdé kapsuly |
cps dur 7x5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/007 |
6808A |
Revlimid 2,5 mg tvrdé kapsuly |
cps dur 7x2,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/13/850/004 |
6799A |
Imnovid 4 mg tvrdé kapsuly |
cps dur 21x4 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/003 |
6798A |
Imnovid 3 mg tvrdé kapsuly |
cps dur 21x3 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/002 |
6542A |
Imnovid 2 mg tvrdé kapsuly |
cps dur 21x2 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/13/850/001 |
6541A |
Imnovid 1 mg tvrdé kapsuly |
cps dur 21x1 mg (blis.PVC/PCTFE/Al) |
CLG-NL |
08.08.2023 |
EU/1/07/391/006 |
3078A |
Revlimid 7,5 mg tvrdé kapsuly |
cps dur 21x7,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/005 |
3077A |
Revlimid 2,5 mg tvrdé kapsuly |
cps dur 21x2,5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/08/488/001 |
64369 |
Vidaza 25 mg/ml prášok na injek?nú suspenziu |
plv inu 1x100 mg (liek.inj.skl.) |
CLG-NL |
|
EU/1/07/391/004 |
43536 |
Revlimid 25 mg tvrdé kapsuly |
cps dur 21x25 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/003 |
43535 |
Revlimid 15 mg tvrdé kapsuly |
cps dur 21x15 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/002 |
43534 |
Revlimid 10 mg tvrdé kapsuly |
cps dur 21x10 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/07/391/001 |
43533 |
Revlimid 5 mg tvrdé kapsuly |
cps dur 21x5 mg (blis. PCTFE/PVC/Al) |
CLG-NL |
|
EU/1/17/1214/001 |
5581C |
Bavencio 20 mg/ml infúzny koncentrát |
con inf 1x10 ml/200 mg (liek.inj.skl.) |
MCK-NL |
20.09.2019 |
EU/1/17/1262/003 |
7444C |
CRYSVITA 30 mg injek?ný roztok |
sol inj 1x1 ml/30 mg (liek.inj.skl.) |
KWH-NL |
19.02.2019 |
EU/1/17/1262/002 |
7443C |
CRYSVITA 20 mg injek?ný roztok |
sol inj 1x1 ml/20 mg (liek.inj.skl.) |
KWH-NL |
19.02.2019 |
EU/1/17/1262/001 |
7442C |
CRYSVITA 10 mg injek?ný roztok |
sol inj 1x1 ml/10 mg (liek.inj.skl.) |
KWH-NL |
19.02.2019 |
EU/1/16/1097/001 |
9509B |
Strimvelis 1 - 10 miliónov buniek/ml infúzna disperzia |
dis inf 1x50 ml (vak.etylénvinylacetát-EVA) |
OCA |
26.05.2021 |
EU/1/18/1305/002 |
9599C |
Cablivi 10 mg prášok a rozpúš?adlo na injek?ný roztok |
plv iol 7x10 mg + 1x1 ml solv. (liek.inj.skl. + striek.inj.napl.skl.) |
ABY |
31.08.2023 |
EU/1/18/1305/001 |
8964C |
Cablivi 10 mg prášok a rozpúš?adlo na injek?ný roztok |
plv iol iol 1x10 mg + 1x1 ml solv. (liek.inj.skl. + striek.inj.napl.skl.) |
ABY |
31.08.2023 |
EU/1/18/1301/001 |
9133C |
Mepsevii 2 mg/ml infúzny koncentrát |
con inf 1x5 ml/10 mg (liek.skl.) |
ULT |
23.08.2023 |
EU/1/18/1296/002 |
8921C |
Tegsedi 284 mg injek?ný roztok naplnený v injek?nej strieka?ke |
sol inj 4x1,5 ml (striek.inj.napl.skl.) |
AKC |
06.07.2023 |
EU/1/18/1296/001 |
8920C |
Tegsedi 284 mg injek?ný roztok naplnený v injek?nej strieka?ke |
sol inj 1x1,5 ml (striek.inj.napl.skl.) |
AKC |
06.07.2023 |
EU/1/06/378/017 |
31927 |
Inovelon 40 mg/ml perorálna suspenzia |
sus por 1x460 ml/18,4 g (f?.PET) |
XEI-DE |
|
EU/1/06/378/016 |
37881 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 200x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/015 |
37880 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 100x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/014 |
37879 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 60x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/013 |
37878 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 50x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/012 |
37877 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 30x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/011 |
37876 |
Inovelon 400 mg filmom obalené tablety |
tbl flm 10x400 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/010 |
37875 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 100x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/009 |
37874 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 60x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/008 |
37873 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 50x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/007 |
37872 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 30x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/006 |
37871 |
Inovelon 200 mg filmom obalené tablety |
tbl flm 10x200 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/005 |
37870 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 100x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/004 |
37869 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 60x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/003 |
37868 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 50x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/002 |
37867 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 30x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/06/378/001 |
37866 |
Inovelon 100 mg filmom obalené tablety |
tbl flm 10x100 mg (blis. PA/Al/PVC) |
XEI-DE |
|
EU/1/18/1276/002 |
9166C |
Myalepta 11,3 mg prášok na injek?ný roztok |
plv ino 30x11,3 mg (liek.inj.skl.) |
AEG-NL |
30.07.2023 |
EU/1/18/1276/001 |
9165C |
Myalepta 11,3 mg prášok na injek?ný roztok |
plv ino 1x11,3 mg (liek.inj.skl.) |
AEG-NL |
30.07.2023 |
EU/1/18/1299/001 |
9269C |
YESCARTA |
dis inf 1x68 ml (vak etylénvinylacetátový) |
KIT |
23.08.2023 |
EU/1/16/1139/004 |
7805C |
OCALIVA 10 mg filmom obalené tablety |
tbl flm 100x10 mg (f?.HDPE) |
IEC |
15.12.2018 |
EU/1/16/1139/003 |
7804C |
OCALIVA 5 mg filmom obalené tablety |
tbl flm 100x5 mg (f?.HDPE) |
IEC |
15.12.2018 |